Table 2.
Kidney inflammatory molecule-1 in inflamed kidney, diabetes and inflamed kidney with diabetes in females patients
| Groups | Mean ± SD | % of KIM-1 efficiency | Correlation between KIM-1 and disease severity | |
|---|---|---|---|---|
| r | P< | |||
| Healthy | 147.18e ± 21.70 | --- | --- | --- |
| Inflamed kidney | 2875.98b ± 275.72 | --- | 0.86* | 0.0001 |
| Treated inflamed kidney | 2497.43c ± 254.22 [-30.54] | 257.20 | 0.76* | 0.0300 |
| Diabetes | 1485.81d ± 18.50 | --- | 0.72 | 0.0080 |
| Treated diabetes | 1288.72d ± 36.54 [-13.16] | 133.91 | 0.94* | 0.0010 |
| Diabetes with inflamed kidney | 3806.52a ± 108.19 | --- | 0.81* | 0.0001 |
| Treated diabetes with inflamed kidney | 2630.16b ± 91.08 [-30.90] | 119.82 | 0.87* | 0.0001 |
Data are expressed as mean ± SD of 15 females in each group.
Values are expressed as pg/ml.
Statistical analysis is carried out using one way analysis of variance test (ANOVA), Costat Computer Program accompanied with least significance difference between groups (LSD) at p < 0.05.
Unshared superscript letters between groups are the significance value at p < 0.0001.
*is the significance level between the KIM-1 level and the disease severity.
Values between parentheses are percentage change over diseased group.
% of efficiency = [(mean of treated group- mean of diseased group)/mean of healthy group] × 100.